Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with Biologics.
Sign Up to like & getrecommendations! Published in 2025 at "American journal of respiratory and critical care medicine"
DOI: 10.1164/rccm.202501-0246oc
Abstract: RATIONALE Although clinical trials have documented the oral corticosteroid (OCS)-sparing effect of biologics in patients with severe asthma, little is known about whether this translates to a reduction of new-onset OCS-related adverse outcomes. OBJECTIVE To… read more here.
Keywords: new onset; related adverse; ocs related; adverse outcomes ... See more keywords
Economic impact of steroid-induced comorbidities in severe asthma: a SHARP CRC simulation
Sign Up to like & getrecommendations! Published in 2025 at "ERJ Open Research"
DOI: 10.1183/23120541.00106-2025
Abstract: Background Patients with severe asthma (SA) consume roughly 50% of the global asthma healthcare resources due to unscheduled visits, hospitalisations, therapy and management of oral corticosteroid (OCS)-related adverse events (AEs). Biologics offer a route away… read more here.
Keywords: impact steroid; ocs related; ocs; severe asthma ... See more keywords